TIDMSENS
RNS Number : 8579N
Sensyne Health PLC
06 June 2022
Sensyne Health plc
("Sensyne" or the "Company")
Results of General Meeting
Oxford, U.K. 6 June 2022: Sensyne Health plc (LSE:SENS) today
announces that at the General Meeting held earlier today all
resolutions proposed were duly passed by shareholders.
The full text of the resolutions is set out in the Notice of
General Meeting in Part IV of the Circular which was sent to
shareholders on 18 May 2022 (the "Circular") and is available from
the Company's website at
https://www.sensynehealth.com/investors/shareholder-information
.
Terms used in this announcement shall be as defined in the
Circular unless the context requires otherwise.
Voting on the resolutions was conducted by way of a poll and a
summary of the votes received is as follows:
R es No.* V otes % V otes % V otes % of Votes
For Against Total ISC Withheld***
1. Approval
of the Sub-division
of the Ordinary
Shares 94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
----------- ------- ---------- ------ ------------ ------ -------------
2. Amend the
Articles to
include the
rights of Deferred
Shares 94,832,989 94.99% 5,002,018 5.01% 99,835,007 60.06 3,160,310
----------- ------- ---------- ------ ------------ ------ -------------
3. Authority
to convert
Loan Notes
into Ordinary
Shares 94,832,989 94.99% 5,002,018 5.01% 99,835,007 60.06 3,160,310
----------- ------- ---------- ------ ------------ ------ -------------
4. Disapplication
of pre-emption
rights in respect
of conversion
of Loan Notes
into Ordinary
Shares 94,832,989 94.99% 5,002,018 5.01% 99,835,007 60.06 3,160,310
----------- ------- ---------- ------ ------------ ------ -------------
5. Authority
to issue Warrants
to subscribe
for Ordinary
Shares 94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
----------- ------- ---------- ------ ------------ ------ -------------
6. Disapplication
of pre-emption
rights in respect
of the issue
of the Warrants 94,932,989 94.99% 5,002,018 5.01% 99,935,007 60.12 3,060,310
----------- ------- ---------- ------ ------------ ------ -------------
7. Approve
the waiver
granted by
the Takeover
Panel of the
obligation
under Rule
9 of the Takeover
Code** 63,035,642 96.20% 2,487,708 3.80% 65,523,350 39.42 3,118,462
----------- ------- ---------- ------ ------------ ------ -------------
8. Cancellation
of the admission
to trading
on AIM per
Rule 41 of
the AIM Rules 95,131,382 92.47% 7,746,581 7.53% 102,877,963 61.89 117,354
----------- ------- ---------- ------ ------------ ------ -------------
9. Approval
of the Re-registration
of the Company
as a private
company 94,975,899 95.09% 4,899,654 4.91% 99,875,553 60.08 3,119,764
----------- ------- ---------- ------ ------------ ------ -------------
10. Adopt the
New Articles
upon the Re-registration 94,975,899 95.09% 4,899,654 4.91% 99,875,553 60.08 3,119,764
----------- ------- ---------- ------ ------------ ------ -------------
* Resolutions numbered 1, 3, 5 and 7 were proposed and passed as
ordinary resolutions and resolutions numbered 2, 4, 6, 8, 9 and 10
were proposed and passed as special resolutions.
** In accordance with the Takeover Code, the Rule 9 Waiver
Resolution (resolution 7) was taken on a poll of Independent
Shareholders.
***A vote withheld is not a vote in law and means the percentage
of votes cast for and against excludes withheld votes.
As at 31 May 2022, the Company's issued share capital comprised
of 166,464,335 Ordinary Shares, with each such Ordinary Share
carrying the right to one vote. The total voting rights of the
Company on the day on which shareholders had to be on the register
of members in order to be eligible to vote at the General Meeting
was 166,464,335 .
Expected timetable for Delisting and Re-registration
The Company confirms that, as at today's date, the expected
timetable for the cancellation of the admission to trading on AIM
of the Company's Ordinary Shares is as follows:
Event* Date**
Last day of dealings on AIM in the Ordinary 17 June 2022
Shares
Cancellation of the admission to trading 7.00 a.m. on 20 June
on AIM of the Ordinary Shares 2022
Re-registration as a private limited On or around 4 July
company 2022
* Each of the times and dates set out in the above timetable are
subject to change by the Company, in which event details of the new
times and dates will be notified to London Stock Exchange plc and
the Company will make an appropriate announcement to a Regulatory
Information Service.
** References to times are to London time.
-ENDS-
Contact details:
Sensyne Health
Alex Snow, Chief Executive Officer
Richard Pye, Chief Financial Officer +44 (0) 330 058 1845
Peel Hunt LLP (Nominated Adviser and Broker) +44 (0) 20 7418 8900
Dr Christopher Golden
James Steel
Consilium Strategic Communications
Mary-Jane Elliott +44 (0) 7780 600290
Jessica Hodgson
CSCSensynehealth@consilium-comms.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ROMFQLFBLQLZBBL
(END) Dow Jones Newswires
June 06, 2022 07:46 ET (11:46 GMT)
Sensyne Health (LSE:SENS)
Historical Stock Chart
From Dec 2024 to Jan 2025
Sensyne Health (LSE:SENS)
Historical Stock Chart
From Jan 2024 to Jan 2025
